<DOC>
	<DOCNO>NCT01429870</DOCNO>
	<brief_summary>Objective ( ) : ( ) To assess effect adjunctive topical steroid combine treatment UVBnb dithranol remission time therapy till relapse psoriasis define 50 % loss PASI ( Psoriasis Area Severity Index ) improvement obtain antecedent treatment . ( ii ) To assess impact adjuvant topical steroid combine treatment UVBnb dithranol clearing time psoriasis lesion therapy ( PASI 75 ) . - Trial medicinal product</brief_summary>
	<brief_title>Steroids Added Dithranol Narrow Band UVB ( Ultraviolet B ) ( UVBnb ) Psoriasis</brief_title>
	<detailed_description>( ) To assess effect adjunctive topical steroid combine treatment UVBnb dithranol remission time therapy till relapse psoriasis define 50 % loss PASI ( Psoriasis Area Severity Index ) improvement obtain antecedent treatment . ( ii ) To assess impact adjuvant topical steroid combine treatment UVBnb dithranol clearing time psoriasis lesion therapy ( PASI 75 ) . - Trial medicinal product</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<mesh_term>Anthralin</mesh_term>
	<criteria>Inclusion criterion : Moderate severe psoriasis chronicplaque / guttata type Exclusion criterion : Participation Goeckerman therapy regimen within 6 month previous present study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>